Weekly Pharma & Life Science News Round-Up: 6th February – 10th February 2023
A round-up of the latest news from the Pharma & Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 6th February – 10th February 2023.
Labcorp Unveils New Name for Future Independent Clinical Development Business – Fortrea
Labcorp (NYSE: LH), a leading global life sciences company, announces that the new company to be formed by the planned spin-off of its Clinical Development business will be known as Fortrea.
GE HealthCare (Nasdaq: GEHC) announces that it has signed an agreement to acquire Caption Health, Inc., a privately owned artificial intelligence (AI) healthcare leader that creates clinical applications to aid in early disease detection, using AI to assist in conducting ultrasound scans.
Veranova Completes Mid-Scale API Expansion at Edinburgh, UK Facility
Veranova’s subsidiary, Macfarlan Smith announces the completion of a $10 million expansion of its mid-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Edinburgh, UK facility.
BSI Life Sciences and Ledger Run Partner to Streamline Clinical Business Operations
BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting and payments, announces their partnership.
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announces that the Company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences (“RS”).
HCB Joins NPG Health to Create Next Generation Healthcare Offering
HCB Health announces it has joined The Next Practices Group (NPG) to become one of the foundational agencies for NPG Health, its global healthcare platform.
Medical Futurist Names Three Trends Shaping the Future of Pharma
Empowered patients, robots and artificial intelligence are reshaping the pharmaceutical supply chain, says Dr Bertalan Meskó, Director of The Medical Futurist Institute.
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, announces its involvement in the development of a major new campus for life science businesses in Stevenage, Hertfordshire.
Spinout Develops Open-Source Software for the Pharmaceutical Industry
Open-source software (OSS), where the source code is available for anyone to use, modify, and distribute, is becoming increasingly common in academia but, because it is difficult to commercialise, is less used in industry.
Advanced Clinical Named 2023 Best of Staffing® Client and Talent Award Winner
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, has earned the Best of Staffing® Client and Talent Awards by ClearlyRated for the eighth consecutive year and Diamond Award status for the fourth consecutive year.
Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI
Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing (NLP) solutions.
Spencer Health Solutions, Inc. (SHS) announces that it has signed a collaboration agreement with Perigon Pharmacy 360 (Perigon). This agreement will expand the reach of its innovative, in-home digital medication adherence-promoting technology with the help of Perigon’s existing end-to-end, specialty pharmacy support programs for patients living with rare, chronic, and complex conditions.
Avania, a leading, global medical technology contract research organization (CRO), announces its acquisition of MAXIS, a prominent medical technology development service provider with expertise in pre-clinical engineering, design validation and verification, regulatory affairs, field clinical services, and trial management.
M&B Sciences Releases Neighborhood Trials App To Improve Diversity In Clinical Trials
M&B Sciences is proud to introduce the NeighborhoodTrials mobile app, which will make it easier for patients from diverse backgrounds to find clinical trials close to home.
Boston-based Bioviser Lending Scientific Expansions to Healthcare Now in the UK and Europe
Founded three years ago, BIOVISER has been supporting global healthcare, pharmaceutical, biological, and medical device organizations to create medical content and documentation, to support market access, reimbursement and evidence creation amongst many other bespoke scientific and regulatory activities.
ZS to Acquire Intelligent Study Design Company Trials.ai
Global management consulting and technology firm ZS announces it has entered into a definitive agreement to acquire Trials.ai, an intelligent study design company.
Nicolas Shiaelis and Dr Nicole Robb, Oxford University scientists and co-founders of health tech company Pictura Bio, have developed a world-first diagnostic, test powered by artificial intelligence, that can identify known respiratory viruses such as influenza and COVID-19 within five minutes from just one nasal or throat swab.
Editor Details
Related Links
- Website: Pharma & Life Science News
- Website: Pharma & Life Science Jobs
